Patients and public: A one-stop resource

Welcome to the patients and public area of the MHRA website. This section provides targeted links to information throughout the site which is aimed specifically at patients and the public.

The section includes latest news and hot topics for the MHRA, details on reporting safety problems and information on specific medicines, devices and conditions.

If you have any feedback on this section and how we can improve it please email or fill out our feedback form.

News and hot topics

Man reading a news paper - home

28 Jan 2014 | Cosopt preservative-free eye drops – new interim container to be available from February following safety concerns

Complaints including reports of eye injury have been received about the current design of the dropper, which was introduced in July 2013. As an interim measure, Merck Sharp & Dohme Limited will replace the current container with a new improved design from 10 February 2014.

13 Jan 2014 | Informal agreement on clinical trials regulation

An agreement was reached between the Lithuanian Presidency of the EU and the European Parliament on the Clinical Trials Regulation.

09 Dec 2013 | Class 2 Medicines Recall (action within 48 hours): Jext 300 and 150 micrograms solution for injection in pre-filled pens - ALK-Abelló A/S (EL (13)A/28)

ALK-Abelló Ltd is recalling batches of Jext 300 and 150 micrograms solution for injection in pre-filled pens to patient level due to a potential problem with delivery of the dosage following activation of the auto injector has been identified.

26 Nov 2013 | Company-led drug recall: Boots Pharmaceuticals liquid medicines - The Boots Company PLC - CLDA (13)A08

A potential manufacturing fault with the tamper seal on some Boots Pharmaceuticals liquid medicines has been identified, which may result in small pieces of plastic being found in the medicine.  

The unwanted display of the text is removed here...dont delete this

Contacting the MHRA

Contacting the MHRA - home
This page provides links to information about how to contact the MHRA.
The unwanted display of the text is removed here...dont delete this

Medicines, devices and conditions

Patient and doctor talking - home
This section provides information on specific products and conditions. The products include steroid medicines, hormone replacement therapy (HRT) and information on the human papillomavirus (HPV) vaccine.
The unwanted display of the text is removed here...dont delete this

My medicine: From laboratory to pharmacy shelf

Man reading a patient information leaflet - home
It takes an average of ten years for a chemical compound to make the journey from the laboratory to reach the pharmacy shelf as a medicine. This section provides links to information to help you find out more about the life cycle of medicines from their first scientific discovery through to licensing and ongoing monitoring.

Reporting safety problems

Safety and pharmacovigilance - home

It is crucial that issues with medicines and medical devices are reported to the MHRA, as this allows us to monitor the safety and efficacy of products, and take action if necessary. This page provides links to information about reporting problems with medicines, vaccines and devices.

Buying counterfeit medicines and medicines online

Woman buying a medicine online - home

Counterfeit medicines and medicines bought online are an increasing problem, both in the UK and globally. This page provides links to information about the risks of buying medicines over the internet and counterfeit medicines and devices.

Herbal and homeopathic medicines

Herbal and homeopathic - home

Herbal and homeopathic medicines and substance are medicines in their own right. As with any other medicine they are likely to have an effect on the body and should be used with care.

Medicines and your family

Mother giving medicine to her child - home
This page provides links to further information about the use of medicines in pregnancy and for babies and young children.
Page last modified: 17 October 2013